Cleared Traditional

K823742 - NEUROMOD COMPLEMENT #7724 DUAL CHANNEL

K823742 is an FDA 510(k) clearance for NEUROMOD COMPLEMENT #7724 DUAL CHANNEL, manufactured by Medtronic Vascular. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 39-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1983
Decision
39d
Days
Class 2
Risk

K823742 is an FDA 510(k) clearance for the NEUROMOD COMPLEMENT #7724 DUAL CHANNEL. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medtronic Vascular (Walker, US). The FDA issued a Cleared decision on January 21, 1983 after a review of 39 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K823742

510(k) Number K823742 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 1982
Decision Date January 21, 1983
Days to Decision 39 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
110d faster than avg
Panel avg: 149d · This submission: 39d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 602
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K823742.
AUTO-TENS MODEL I DISPOS. SINGLE CHAN
K823467 · Cbc Corp. · Feb 1983
AUTO-TENS MODEL IV -DUAL CHANNEL FULL
K823464 · Cbc Corp. · Feb 1983
AUTO-TENS MODEL II SINGLE CHANNEL
K823465 · Cbc Corp. · Feb 1983
WRIGHT CARE
K823497 · Dow Corning Wright · Jan 1983
MODEL 402P SEQUENCER FOR EMPI TEMS DEV
K823299 · Epmi, Inc. · Dec 1982
VERIL/PPR PERSONAL PAIN RELIEVER #800
K822929 · Verite · Nov 1982